tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Otsuka’s VOYXACT Gains FDA Approval for IgAN Treatment
Company AnnouncementsOtsuka’s VOYXACT Gains FDA Approval for IgAN Treatment
27d ago
Cullinan Therapeutics and partners initiate NDA application for zipalertinib
PremiumThe Fly
Cullinan Therapeutics and partners initiate NDA application for zipalertinib
1M ago
Otsuka’s Sibeprenlimab Shows Promising Results in IgAN Treatment
PremiumCompany Announcements
Otsuka’s Sibeprenlimab Shows Promising Results in IgAN Treatment
1M ago
Otsuka Holdings Reports Strong Nine-Month Earnings Growth
PremiumCompany Announcements
Otsuka Holdings Reports Strong Nine-Month Earnings Growth
2M ago
Otsuka Holdings Reports Strong Financial Growth and Expands Consolidation
PremiumCompany Announcements
Otsuka Holdings Reports Strong Financial Growth and Expands Consolidation
2M ago
OTSKF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsOTSKF Upcoming Earnings Report: What to Expect?
2M ago
Otsuka Holdings Completes Strategic Share Transfer
Premium
Company Announcements
Otsuka Holdings Completes Strategic Share Transfer
3M ago
FDA Issues Complete Response Letter to Otsuka and Lundbeck for PTSD Treatment
Premium
Company Announcements
FDA Issues Complete Response Letter to Otsuka and Lundbeck for PTSD Treatment
3M ago
Otsuka Holdings Amends Share Transfer Agreement for Otsuka Medical Devices
PremiumCompany Announcements
Otsuka Holdings Amends Share Transfer Agreement for Otsuka Medical Devices
4M ago
Otsuka Holdings Reports Strong Growth in H1 2025
PremiumCompany Announcements
Otsuka Holdings Reports Strong Growth in H1 2025
5M ago
Otsuka Holdings Reports Strong H1 2025 Financial Results and Increases Dividend Forecast
PremiumCompany Announcements
Otsuka Holdings Reports Strong H1 2025 Financial Results and Increases Dividend Forecast
5M ago
Otsuka Holdings Increases Interim and Annual Dividend Forecast
PremiumCompany Announcements
Otsuka Holdings Increases Interim and Annual Dividend Forecast
5M ago
Otsuka Holdings Upgrades Financial Forecast for FY2025
PremiumCompany AnnouncementsOtsuka Holdings Upgrades Financial Forecast for FY2025
5M ago
Otsuka Medical Devices Sells Stake in MicroPort to Boost Growth
Premium
Company Announcements
Otsuka Medical Devices Sells Stake in MicroPort to Boost Growth
5M ago
FDA Committee Reviews Otsuka and Lundbeck’s PTSD Treatment Application
Premium
Company Announcements
FDA Committee Reviews Otsuka and Lundbeck’s PTSD Treatment Application
5M ago
U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz
PremiumThe Fly
U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz
7M ago
DE
ZM
Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data
PremiumThe Fly
Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data
7M ago
VERA
Otsuka’s Sibeprenlimab Shows Promising Results in Phase 3 IgAN Study
PremiumCompany Announcements
Otsuka’s Sibeprenlimab Shows Promising Results in Phase 3 IgAN Study
7M ago
Otsuka’s Sibeprenlimab BLA Accepted by FDA for Priority Review
PremiumCompany Announcements
Otsuka’s Sibeprenlimab BLA Accepted by FDA for Priority Review
7M ago
Otsuka Holdings Announces Change in Major Shareholders
PremiumCompany AnnouncementsOtsuka Holdings Announces Change in Major Shareholders
8M ago
Otsuka Holdings Reports Strong Q1 2025 Performance
Premium
Company Announcements
Otsuka Holdings Reports Strong Q1 2025 Performance
8M ago
Otsuka Holdings Reports Strong Q1 2025 Financial Performance Amid Strategic Expansion
Premium
Company Announcements
Otsuka Holdings Reports Strong Q1 2025 Financial Performance Amid Strategic Expansion
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >